It’s Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?

Lignende værker

• Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS
  af: Caiola, Elisa, et al.
  Udgivet: (2016)
• Generation and characterization of MEK and ERK inhibitors- resistant non-small-cells-lung-cancer (NSCLC) cells
  af: Iezzi, Alice, et al.
  Udgivet: (2018)
• Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo
  af: Brunelli, Laura, et al.
  Udgivet: (2016)
• Molecular determinants of response to PI3K/akt/mTOR and KRAS pathways inhibitors in NSCLC cell lines
  af: Iezzi, Alice, et al.
  Udgivet: (2020)
• Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
  af: Elisa Caiola, et al.
  Udgivet: (2020-07-01)